These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7591838

  • 1. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
    Matsuura M, Hayakawa N, Shimokata H.
    Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
    [Abstract] [Full Text] [Related]

  • 2. Mortality statistics of major causes of death among atomic bomb survivors in Hiroshima Prefecture from 1968 to 1982.
    Hayakawa N, Ohtaki M, Ueoka H, Matsuura M, Munaka M, Kurihara M.
    Hiroshima J Med Sci; 1989 Jun; 38(2):53-67. PubMed ID: 2793517
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
    Zhunussova T, Matsuura M, Hayakawa N.
    Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
    [Abstract] [Full Text] [Related]

  • 4. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP.
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [Abstract] [Full Text] [Related]

  • 5. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP.
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [Abstract] [Full Text] [Related]

  • 6. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y, Mabuchi K, Preston DL, Shigematsu I.
    World Health Stat Q; 1996 Mar; 49(1):35-9. PubMed ID: 8896256
    [Abstract] [Full Text] [Related]

  • 7. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E, Preston DL, Mabuchi K, Thompson DE, Soda M.
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [Abstract] [Full Text] [Related]

  • 8. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV, Prentice RL, Ishimaru T, Kato H, Mason M.
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [Abstract] [Full Text] [Related]

  • 9. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokunaga M, Tokuoka S, Soda M, Mabuchi K, Land CE.
    Cancer; 1997 Apr 15; 79(8):1465-75. PubMed ID: 9118025
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP.
    Int J Radiat Biol; 2001 Apr 15; 77(4):431-64. PubMed ID: 11304437
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiation-induced cancer and its modifying factor among A-bomb survivors.
    Kato H.
    Princess Takamatsu Symp; 1987 Apr 15; 18():117-24. PubMed ID: 3506538
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants.
    Kato H, Brown CC, Hoel DG, Schull WJ.
    Radiat Res; 1982 Aug 15; 91(2):243-64. PubMed ID: 7100400
    [No Abstract] [Full Text] [Related]

  • 17. Relationship of cigarette smoking and radiation exposure to cancer mortality in Hiroshima and Nagasaki.
    Prentice RL, Yoshimoto Y, Mason MW.
    J Natl Cancer Inst; 1983 Apr 15; 70(4):611-22. PubMed ID: 6572749
    [Abstract] [Full Text] [Related]

  • 18. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K, Fujiwara S, Yamada M, Kasagi F, Shimizu Y, Shigematsu I.
    World Health Stat Q; 1996 Apr 15; 49(1):7-16. PubMed ID: 8896251
    [Abstract] [Full Text] [Related]

  • 19. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S, Nakashima M, Ito M, Kondo H, Meirmanov S, Hayashi T, Soda M, Matsuo T, Sekine I.
    Cancer; 2008 May 15; 112(10):2143-51. PubMed ID: 18348306
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
    Howe GR, McLaughlin J.
    Radiat Res; 1996 Jun 15; 145(6):694-707. PubMed ID: 8643829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.